» Articles » PMID: 27193358

Disability Rating Scales in Parkinson's Disease: Critique and Recommendations

Overview
Journal Mov Disord
Date 2016 May 20
PMID 27193358
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: PD is associated with impairments that progress over time to disability. A large number of disability scales exist with little information on the best choice in PD.

Methods: Following methodology adopted by the International Parkinson and Movement Disorder Society Task Force, a review of disability scales used in PD was completed. Based on prespecified criteria, the review categorized scales into: "Recommended"; "Recommended with Further Validation in PD Required" when well-validated scales have not been specifically tested for clinimetric properties in PD; "Suggested"; and "Listed."

Results: Twenty-nine disability instruments were identified with nine scales fulfilling criteria for "Recommended" and 7 "Recommended with Further Validation in PD Required." Eight scales are "Suggested" and five scales are "Listed" for use in PD. The nine Recommended scales (Functional Status Questionnaire, Lawton-Brody Activities of Daily Living, Nottingham Activities of Daily Living, Schwab and England Activities of Daily Living, Self-Assessment PD Disability, Short Parkinson's Evaluation Scale/Scales for Outcomes in PD, Unified PD Rating Scale-II: Activities of Daily Living, Movement Disorders Society UPDRS Motor Experiences of Daily Living, PROMIS and Neuro-QoL Physical Function), and the seven Recommended with Further Validation in PD Required are reviewed.

Conclusion: Many disability measures are available and recommended for application in PD. The Task Force does not recommend the development of a new scale. Selection of the most appropriate instrument for a particular objective requires consideration of the characteristics of each scale and the goals of the assessment. © 2016 International Parkinson and Movement Disorder Society.

Citing Articles

Cognition and Activity of Daily Living Function in people with Parkinson's disease.

Bode M, Kalbe E, Liepelt-Scarfone I J Neural Transm (Vienna). 2024; 131(10):1159-1186.

PMID: 38976044 PMC: 11489248. DOI: 10.1007/s00702-024-02796-w.


Characterization of Walking in Mild Parkinson's Disease: Reliability, Validity and Discriminant Ability of the Six-Minute Walk Test Instrumented with a Single Inertial Sensor.

Bailo G, Saibene F, Bandini V, Arcuri P, Salvatore A, Meloni M Sensors (Basel). 2024; 24(2).

PMID: 38276354 PMC: 10821195. DOI: 10.3390/s24020662.


Duration of rehabilitation therapy to achieve a minimal clinically important difference in mobility, walking endurance and patient-reported physical health: an observational study.

Kool N, Kool J, Bachmann S J Rehabil Med. 2023; 55:jrm12322.

PMID: 37987632 PMC: 10680980. DOI: 10.2340/jrm.v55.12322.


The STEPWISE study: study protocol for a smartphone-based exercise solution for people with Parkinson's Disease (randomized controlled trial).

Schootemeijer S, de Vries N, Macklin E, Roes K, Joosten H, Omberg L BMC Neurol. 2023; 23(1):323.

PMID: 37700241 PMC: 10496249. DOI: 10.1186/s12883-023-03355-8.


Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson's disease.

Liikkanen S, Sinkkonen J, Suorsa J, Kaasinen V, Pekkonen E, Karppa M PLOS Digit Health. 2023; 2(4):e0000225.

PMID: 37027348 PMC: 10081770. DOI: 10.1371/journal.pdig.0000225.